Aaipharma Inc (1013243) SEC Filing 10-Q Quarterly report for the period ending Thursday, September 30, 2004

Aaipharma Inc

CIK: 1013243

View differences made from one quarter to another to evaluate Aaipharma Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aaipharma Inc.


Assess how Aaipharma Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aaipharma Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1013243
Form Type: 10-Q Quarterly Report
Accession Number: 0000950144-04-010756
Submitted to the SEC: Tue Nov 09 2004 4:26:29 PM EST
Accepted by the SEC: Tue Nov 09 2004
Period: Thursday, September 30, 2004
Industry: Testing Laboratories

External Resources:

Bookmark the Permalink: